Verition Fund Management LLC Biogen Inc. Put Options Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $209,572 - $260,392	-1,100 Reduced 12.22%	7,900 $1.83 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $869,282 - $1.1 Million	4,100 Added 83.67%	9,000 $1.94 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $44,518 - $53,588	-200 Reduced 3.92%	4,900 $1.27 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.29 Million - $1.46 Million	5,100 New	5,100 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $681,415 - $939,609	3,500 New	3,500 $935,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $19,377 - $24,414	-100 Reduced 3.7%	2,600 $548,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $764,073 - $996,435	2,700 New	2,700 $764,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.